Linganisha mbinu
Pitia mbinu ulizochagua bega kwa bega; safu zinazotofautiana zinaangaziwa.
| Kinetiki ya Michaelis-Menten× | Uundaji wa Kimodelia wa Madhara ya Dawa kwa Idadi ya Watu× | |
|---|---|---|
| Nyanja | Famakolojia | Famakolojia |
| Familia | Process / pipeline | Process / pipeline |
| Mwaka wa asili≠ | 1913 | 1992 |
| Mwanzilishi≠ | Leonor Michaelis and Maud Menten | Lewis Sheiner and Stephen Roush |
| Aina≠ | mechanistic model | dose-response modeling |
| Chanzo asilia≠ | Michaelis, L., & Menten, M. L. (1913). Die Kinetik der Invertinwirkung. Biochemische Zeitschrift, 49, 333-369. link ↗ | Dahlström, B., & Nyberg, L. (1993). Population pharmacokinetics and pharmacodynamics. Clinical Pharmacokinetics, 24(1), 45-57. link ↗ |
| Majina mbadala | MM kinetics, Michaelis constant, Vmax | PopPD, population PD, hierarchical PD modeling |
| Zinazohusiana≠ | 2 | 3 |
| Muhtasari≠ | Michaelis-Menten kinetics describes the rate of enzyme-catalyzed reactions as a function of substrate concentration. Developed by Leonor Michaelis and Maud Menten in 1913, this foundational framework models enzyme catalysis through the rapid-equilibrium approximation and enables prediction of drug metabolism rates in pharmacokinetics. | Population pharmacodynamic (PopPD) modeling integrates pharmacokinetics with individual dose-response relationships across patient populations to characterize drug efficacy and tolerability. Pioneered by Lewis Sheiner and colleagues, PopPD accounts for inter-individual variability in drug effects and enables rational dose optimization and response prediction. |
| ScholarGateSeti ya data ↗ |
|
|